AGENUS INC — Director's Dealing 2022

Feb 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2022-02-02

Reporting Person: ARMEN GARO H (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-02	Common Stock	A	237011	$2.51	Acquired	1007784	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	125969	Indirect
Common Stock	579000	Indirect

Footnotes

F1: Reflects the executive's 2021 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 6-month lockup restriction with 25% of the award released on the 3-month anniversary of the issuance date and 75% of the award released on the 6-month anniversary.

F2: $2.51 was the fair market value of our Common Stock on February 2, 2022, the stock issuance date.

F3: Shares are held in Dr. Armen's IRA accounts.

F4: Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 479,000 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 100,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.